Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « therapies »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
therapie < therapies < therapy  Facettes :

List of bibliographic references indexed by therapies

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000020 (2020) Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000117 (2020) Vaishali Jayashankar ; Aimee L. EdingerMacropinocytosis confers resistance to therapies targeting cancer anabolism
000293 (2019) Kevin L. Winthrop [États-Unis] ; Michael E. Weinblatt [États-Unis] ; Joan Bathon [États-Unis] ; Gerd R. Burmester [Allemagne] ; Philip J. Mease [États-Unis] ; Leslie Crofford [États-Unis] ; Vivian Bykerk [États-Unis] ; Maxime Dougados [France] ; James Todd Rosenbaum [États-Unis] ; Xavier Mariette [France] ; Joachim Sieper [Allemagne] ; Fritz Melchers [Allemagne] ; Bruce N. Cronstein [États-Unis] ; Ferry C. Breedveld [Pays-Bas] ; Joachim Kalden [Allemagne] ; Josef S. Smolen [Autriche] ; Daniel Furst [États-Unis, Italie]Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019
000316 (2019) Mingzhi Luo [République populaire de Chine] ; Kai Ni [République populaire de Chine] ; Yang Jin [République populaire de Chine] ; Zifan Yu [République populaire de Chine] ; Linhong Deng [République populaire de Chine]Toward the Identification of Extra-Oral TAS2R Agonists as Drug Agents for Muscle Relaxation Therapies via Bioinformatics-Aided Screening of Bitter Compounds in Traditional Chinese Medicine
000524 (2019) Sophia Grimes ; Kira Bombay ; Andrea Lanes ; Mark Walker ; Daniel J. CorsiPotential biological therapies for severe preeclampsia: a systematic review and meta-analysis
000653 (2019) Marina Elena Cazzaniga [Italie] ; Romano Danesi [Italie] ; Corrado Girmenia [Italie] ; Pietro Invernizzi [Italie] ; Alessandra Elvevi [Italie] ; Massimo Uguccioni [Italie]Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success
000A01 (2019) Anjali Patwardhan [États-Unis] ; Charles H. Spencer [États-Unis]Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon
000A23 (2019) Mara Cirone [Italie] ; Maria Saveria Gilardini Montani [Italie] ; Marisa Granato [Italie] ; Alessia Garufi [Italie] ; Alberto Faggioni [Italie] ; Gabriella D Razi [Italie]Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
000C38 (2018) Dana Wai Yi Tsui [Royaume-Uni] ; Muhammed Murtaza [Royaume-Uni] ; Alvin Seng Cheong Wong [Singapour] ; Oscar M. Rueda [Royaume-Uni] ; Christopher G. Smith [Royaume-Uni] ; Dineika Chandrananda [Royaume-Uni] ; Ross A. Soo [Singapour] ; Hong Liang Lim [Singapour] ; Boon Cher Goh [Singapour] ; Carlos Caldas [Royaume-Uni] ; Tim Forshew [Royaume-Uni] ; Davina Gale [Royaume-Uni] ; Wei Liu [Royaume-Uni] ; James Morris [Royaume-Uni] ; Francesco Marass [Royaume-Uni] ; Tim Eisen [Royaume-Uni] ; Tan Min Chin [Singapour] ; Nitzan Rosenfeld [Singapour]Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.
000C77 (2017) Dieudonneé Makaba Mvumbi [République démocratique du Congo] ; Thierry Lengu Bobanga [République démocratique du Congo] ; Jean-Marie Ntumba Kayembe [République du Congo] ; Georges Lelo Mvumbi [République démocratique du Congo] ; Hippolyte Nani-Tuma Situakibanza [République démocratique du Congo] ; F. Benoit-Vical [France] ; Pierrette Melin [Belgique] ; P. De Mol [Belgique] ; Marie-Pierre Hayette [Belgique]Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo
000F19 (2015) Rk Reeves [États-Unis] ; A. Burgener [Canada, Suède] ; Nr Klatt [États-Unis]Targeting the gastrointestinal tract to develop novel therapies for HIV
001259 (2013) C. H. To [République populaire de Chine] ; L. Y. Ho [République populaire de Chine] ; K. L. Yu [République populaire de Chine] ; K. L. Chan [République populaire de Chine] ; P. T. Chan [République populaire de Chine] ; C. C. Mok [République populaire de Chine]AB0362 Tight control of disease activity by conventional DMARDs could minimize the use of biological therapies in patients with early rheumatoid arthritis: Data from an early arthritis clinic in hong kong
001357 (2012) Eamonn S. Molloy [Irlande (pays)] ; Leonard H. Calabrese [États-Unis]Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
001445 (2012) 2.6 Systemic lupus erythematosus, Sjogren's and antiphospholipid syndrome – therapies
001517 (2011) C. Domingo [Espagne, Canada] ; A. Moreno [Espagne] ; R. Mirapeix [Espagne]Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids
001613 (2010) Solange Youdom Whegang ; Rachida Tahar ; Vincent Ngane Foumane ; Georges Soula ; Henri Gwét ; Jean-Christophe Thalabard [France] ; Leonardo K. BascoEfficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
001968 (2008) Robert Kim [États-Unis] ; Keith C. MeyerReview: Therapies for interstitial lung disease: past, present and future
001A27 (2008) David P. Nichols [États-Unis] ; Michael W. Konstan [États-Unis] ; James F. Chmiel [États-Unis]Anti-inflammatory Therapies for Cystic Fibrosis-Related Lung Disease
001C44 (2006) B. Y. H. Thong ; S. Vasoo [Singapour] ; E. T. KohThe use of anti‐tumour necrosis factor‐α therapies for rheumatoid arthritis in Singapore
001E41 (2005) Tanya Doan [États-Unis] ; Elena Massarotti [États-Unis]Rheumatoid Arthritis: An Overview of New and Emerging Therapies

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "therapies" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "therapies" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    therapies
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021